TURNING POINT THERAPEUTICS I's ticker is TPTX and the CUSIP is 90041T108. A total of 206 filers reported holding TURNING POINT THERAPEUTICS I in Q1 2021. The put-call ratio across all filers is 0.28 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2021 | $19,403,000 | -43.7% | 205,124 | -27.4% | 0.29% | -48.6% |
| Q4 2020 | $34,441,000 | +37.4% | 282,649 | -1.5% | 0.56% | +8.0% |
| Q3 2020 | $25,065,000 | +57.6% | 286,917 | +16.5% | 0.52% | +33.1% |
| Q2 2020 | $15,907,000 | +26.6% | 246,269 | -12.4% | 0.39% | -7.9% |
| Q1 2020 | $12,560,000 | -24.6% | 281,239 | +5.1% | 0.42% | -5.2% |
| Q4 2019 | $16,662,000 | +120.2% | 267,498 | +32.9% | 0.44% | +80.1% |
| Q3 2019 | $7,566,000 | -10.3% | 201,230 | -2.9% | 0.25% | -6.8% |
| Q2 2019 | $8,436,000 | – | 207,284 | – | 0.26% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Cormorant Asset Management, LP | 2,392,297 | $291,501,000 | 6.94% |
| Burrage Capital Management LLC | 72,484 | $8,832,000 | 6.73% |
| MPM BioImpact LLC | 617,372 | $75,226,000 | 6.50% |
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 113,541 | $13,816,000 | 3.77% |
| Orbimed Advisors | 2,745,327 | $334,518,000 | 2.93% |
| SECTORAL ASSET MANAGEMENT INC | 257,379 | $31,362,000 | 2.21% |
| Parkman Healthcare Partners LLC | 59,377 | $7,235,000 | 1.85% |
| Nicholas Investment Partners, LP | 183,676 | $22,381,000 | 1.73% |
| EMERALD ADVISERS, LLC | 357,038 | $43,505,000 | 1.44% |
| EMERALD MUTUAL FUND ADVISERS TRUST | 336,173 | $40,963,000 | 1.42% |